Cryptococcal meningitis: Clinical, diagnostic and therapeutic overviews

Neurology India

Volumn 55, Issue 3, 2007, Pages 226-232

  Satishchandra, P ^a   Mathew, T ^a   Gadre, G ^a   Nagarathna, S ^a   Chandramukhi, A ^a   Mahadevan, A ^a   Shankar, S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Cryptococcal; HIV; Immunodeficiency; Meningitis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIINFLAMMATORY AGENT; ANTIRETROVIRUS AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLINDNESS; BRAIN INFECTION; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCAL MENINGITIS; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; HEMATOLOGIC MALIGNANCY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUMBAR PUNCTURE; MANOMETRY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; PATHOGENESIS; PROGNOSIS; QUALITY OF LIFE; REVIEW; TUBERCULOUS MENINGITIS; UNSPECIFIED SIDE EFFECT;

EID: 35048885012     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.35683     Document Type: Review

References (42)

1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995;8:515-48.
2. Currie BP, Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis 1994;19:1029-33.
3. Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 1990;12:768-77.
4. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Holmberg SD and HIV Outpatient Study Investigators. Declining mortality and morbidity among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
5. Kumarasamy N, Solomon S, Chaguturu SK, Cecelia AJ, Vallabhaneni S, Flanigan TP, et al. The changing natural history of HIV disease: Before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis 2005;41:1525-8.
6. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: An update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003;36:789-94.
7. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var grubii: Separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999;37:838-40.
8. Litvintseva AP, Thakur R, Reller LB, Mitchell TG. Prevalence of clinical isolates of Cryptoccus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis 2005;192:888-92.
9. th ed. The McGraw-Hill Co: USA; 2005. p. 1183-5.
10. Jain N, Wickes BL, Keller SM, Fu J, Casadevall A, Jain P, et al. Molecular epidemiology of clinical cryptococcus strains from India. J Clin Microbiol 2005;43:5733-42.
11. Gugnani HC, Mitchell TG, Litvintseva AP, Lengeler KB, Heitman J, Kumar A, et al. Isolation of Cryptococcus gattii and Cryptococcus neoformans var. grubii from the flowers and bark of Eucalyptus trees in India. Med Mycol 2005;43:565-9.
12. Randhawa HS, Kowshik T, Preeti Sinha K, Chowdhary A, Khan ZU, Yan Z, et al. Distribution of Cryptococcus gattii and Cryptococcus neoformans in decayed trunk wood of Syzygium cumini trees in north-western India. Med Mycol 2006;44:623-30.
13. th ed. Mosby, Inc: USA; 2002.p. 724-5.
14. Casadevall A, Rosas AL, Nosanchuk JD. Melanin and virulence in Cryptococcus neoformans. Curr Opin Microbiol 2000;3:354-8.
15. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-9.
16. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, et al. Profile of neurological disorders associated with HIV/AIDS from South India (1989 - 1996). Indian J Med Res 2000;111:14-23.
17. Brew BJ. Cryptococcal meningitis. In: HIV neurology. Oxford University Press: New York; 2001. p. 91-6.
18. Leite AG, Vidal JE, Bonasser Filho F, Nogueira RS, Oliveira AC. Cerebral infarction related to cryptococcal meningitis in an HIV-infected patient: case report and literature review. Braz J Infect Dis 2004;8:175-9.
19. Mohan S, Ahmed SI, Alao OA, Schliep TC. A case of AIDS associated cryptococcal meningitis with multiple cranial nerve neuropathies. Clin Neurol Neurosurg 2006;108:610-3.
20. Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis 2006;10:72-8.
21. Helbok R, Pongpakdee S, Yenjun S, Dent W, Beer R, Lackner P, et al. Chronic meningitis in Thailand: Clinical characteristics, laboratory data and outcome in patients with specific reference to tuberculosis and cryptococcosis. Neuroepidemiology 2006;26:37-44.
22. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000;31:499-508.
23. Santosh V, Yasha TC, Panda KM. Pathology of AIDS: Study from a neuropsychiatric center from south India. Ann Indian Acad Neurol 1998;1:71-82.
24. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991;91:267-72.
25. Graybill JR, Sobel J. The role of lumbar puncture in the management of elevated intracranial pressure in patients with AIDS-associated cryptococcal meningitis. Clin Infect Dis 2000;31:1310-1.
26. Chuck L, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-9.
27. Khanna N, Chandramukhi A, Desai A, Ravi V. Cryptococcal infection of the central nervous system and analysis of predisposing factors, laboratory findings and outcome inpatients from South India with special reference to HIV infection. J Med Microbiol 1996;45:376-9.
28. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001;33:690-9.
29. Casadevall A, Perfect JR. Cryptococcus neoformans. ASM Press: Washington DC; 1998.
30. Lu H, Zhou Y, Yin Y, Pan X. Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. J Clin Microbiol 2005;43:2989-90.
31. Khanna N, Chandramuki A, Desai A, Ravi V, Santhosh V, Shankar SK, et al. Cryptococcosis in the immunocompromized host with special reference to AIDS. Indian J Chest Dis Allied Sci 2000;42:311-5.
32. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of Cryptococcal disease. Clin Infect Dis 2000;30:710-8.
33. Chen SC; Australasian Society for Infectious Diseases (ASID) Mycoses Iterest Group. Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B. J Antimicrob Chemother 2002;49:57-61.
34. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997;337:15-21.
35. Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002;35:e128-33.
36. Skiest DJ, Hester LJ, Hardy RD. Cryptococcal immune reconstitution inflammatory syndrome: Report of four cases in three patients and review of the literature. J Infect 2005;51:e289-97.
37. De Schacht C, Smets RM, Callens S, Colebunders R. Bilateral blindness after starting highly active antiretroviral treatment in a patient with HIV infection and cryptococcal meningitis. Acta Clin Belg 2005;60:10-2.
38. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: A study in 111 cases. Ann Intern Med 1974;80:176-81.
39. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000;30:47-54.
40. Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennett JE. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine 1993;72:207-24.
41. Popovich MJ, Arthur RH, Helmer E. CT of intracranial cryptococcosis. AJR Am J Roentgenol 1990;154:603-6.
42. Cornell SH, Jacoby CG. The varied computed tomographic appearance of intracranial cryptococcosis. Radiology 1982;143:703-7.